Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1682
+0.0026(+0.22%)
GBP/USD
1.2494
-0.0017(-0.14%)
Bitcoin GBP
51,139.66
-768.11(-1.48%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

24.36

+0.53

(+2.22%)

At close: 04:00PM EDT

24.36

0.00

(0.00%)

After hours:

04:20PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	1.90B
Enterprise value	1.31B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	182.00
Price/book (mrq)	3.79
Enterprise value/revenue	137.47
Enterprise value/EBITDA	-5.63

Trading information

Stock price history

Beta (5Y monthly)	0.77
52-week change ³	92.18%
S&P500 52-week change ³	21.08%
52-week high ³	27.66
52-week low ³	4.82
50-day moving average ³	21.69
200-day moving average ³	11.61

Share statistics

Avg vol (3-month) ³	1.16M
Avg vol (10-day) ³	882.39k
Shares outstanding ⁵	79.72M
Implied shares outstanding ⁶	79.72M
Float ⁸	67.97M
% held by insiders ¹	6.41%
% held by institutions ¹	85.69%
Shares short (15 Apr 2024) ⁴	10.66M
Short ratio (15 Apr 2024) ⁴	9.14
Short % of float (15 Apr 2024) ⁴	13.53%
Short % of shares outstanding (15 Apr 2024) ⁴	13.37%
Shares short (prior month 15 Mar 2024) ⁴	8.62M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-3,043.46%

Management effectiveness

Return on assets (ttm)	-23.24%
Return on equity (ttm)	-39.34%

Income statement

Revenue (ttm)	9.56M
Revenue per share (ttm)	0.13
Quarterly revenue growth (yoy)	-20.80%
Gross profit (ttm)	N/A
EBITDA	-233.5M
Net income avi to common (ttm)	-212.22M
Diluted EPS (ttm)	-2.91
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	595.35M
Total cash per share (mrq)	7.47
Total debt (mrq)	9.85M
Total debt/equity (mrq)	1.97%
Current ratio (mrq)	7.58
Book value per share (mrq)	6.32

Cash flow statement

Operating cash flow (ttm)	-119.06M
Levered free cash flow (ttm)	-86.66M